ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
Related Collections
Right arrowRelated Article

Ann Thorac Surg 1997;64:953
© 1997 The Society of Thoracic Surgeons

Discussion

Discussion

The first 20% of the full text of this article appears below.

See also page 949.

DR G. ALEXANDER PATTERSON (St. Louis, MO): What do you think is the stimulus for downregulation or lack of expression? Is it some circulating growth factor that comes from somewhere else, or is there something deficient in the way integrin molecules are produced in those tumors? Can you make any speculation?

DR SMYTHE:The answer to that very good question is an important one. . . . [Full Text of this Article]


Related Article

Loss of {alpha}v Integrin Expression and Recurrence in Node-Negative Lung Carcinoma
W. Roy Smythe, Dahlia Wasfi, Joseph E. Bavaria, Steven M. Albelda, and Larry R. Kaiser
Ann. Thorac. Surg. 1997 64: 949-953. [Abstract] [Full Text]





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1997 by The Society of Thoracic Surgeons.